-
Signature
-
/s/ Douglas W. Pagan, attorney-in-fact
-
Stock symbol
-
DRNA
-
Transactions as of
-
Jun 3, 2021
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
6/7/2021, 09:34 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DRNA |
Common Stock |
Options Exercise |
|
+3.33K |
|
|
3.33K |
Jun 3, 2021 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DRNA |
Restricted Stock Units |
Options Exercise |
$0 |
-3.33K |
-100% |
$0.00* |
0 |
Jun 3, 2021 |
Common Stock |
3.33K |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Anna Protopapas is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses: